LabConnect and The Bracken Group Forge Strategic Partnership to Enhance Radiopharmaceutical Trial Support
LabConnect's collaboration with The Bracken Group addresses the growing demand for specialized radiopharmaceutical expertise in clinical trials, positioning the partnership to better serve biotech and pharmaceutical companies developing targeted treatments and diagnostics.
